Intrepid Capital Management Inc. Increases Holdings in AmerisourceBergen Corp. (NYSE:ABC)

Intrepid Capital Management Inc. raised its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 1.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 109,144 shares of the company’s stock after acquiring an additional 1,849 shares during the period. AmerisourceBergen accounts for 4.2% of Intrepid Capital Management Inc.’s investment portfolio, making the stock its 5th biggest position. Intrepid Capital Management Inc.’s holdings in AmerisourceBergen were worth $8,679,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund grew its holdings in shares of AmerisourceBergen by 6,614.4% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,448,589 shares of the company’s stock valued at $46,000 after acquiring an additional 3,397,228 shares in the last quarter. FMR LLC grew its holdings in shares of AmerisourceBergen by 51.7% during the 4th quarter. FMR LLC now owns 7,263,899 shares of the company’s stock valued at $540,434,000 after acquiring an additional 2,474,112 shares in the last quarter. Boston Partners grew its holdings in shares of AmerisourceBergen by 222.4% during the 1st quarter. Boston Partners now owns 2,343,027 shares of the company’s stock valued at $186,317,000 after acquiring an additional 1,616,201 shares in the last quarter. Norges Bank purchased a new position in shares of AmerisourceBergen during the 4th quarter valued at $103,863,000. Finally, Millennium Management LLC boosted its holdings in AmerisourceBergen by 971.5% in the fourth quarter. Millennium Management LLC now owns 651,384 shares of the company’s stock worth $48,463,000 after purchasing an additional 590,591 shares in the last quarter. 66.56% of the stock is currently owned by institutional investors.

A number of brokerages recently issued reports on ABC. Zacks Investment Research upgraded shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $89.00 price objective for the company in a report on Wednesday. Argus decreased their price objective on shares of AmerisourceBergen from $115.00 to $100.00 and set a “buy” rating for the company in a report on Monday, June 3rd. ValuEngine upgraded shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a report on Wednesday, May 22nd. Guggenheim began coverage on shares of AmerisourceBergen in a report on Thursday, April 11th. They issued a “buy” rating for the company. Finally, Bank of America cut shares of AmerisourceBergen from a “buy” rating to an “underperform” rating and decreased their price objective for the stock from $95.00 to $76.00 in a report on Wednesday, April 10th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $88.33.

AmerisourceBergen stock traded down $0.50 on Friday, reaching $85.94. 8,263 shares of the stock were exchanged, compared to its average volume of 1,310,331. The firm has a market cap of $17.94 billion, a price-to-earnings ratio of 13.21, a P/E/G ratio of 1.65 and a beta of 0.92. The company has a debt-to-equity ratio of 1.43, a current ratio of 0.95 and a quick ratio of 0.56. AmerisourceBergen Corp. has a twelve month low of $69.36 and a twelve month high of $94.88.

AmerisourceBergen (NYSE:ABC) last released its earnings results on Thursday, May 2nd. The company reported $2.11 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.96 by $0.15. The firm had revenue of $43.32 billion during the quarter, compared to analyst estimates of $43.44 billion. AmerisourceBergen had a net margin of 0.53% and a return on equity of 46.24%. The business’s revenue was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.94 EPS. As a group, sell-side analysts expect that AmerisourceBergen Corp. will post 6.84 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Monday, June 3rd. Shareholders of record on Monday, May 20th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.86%. The ex-dividend date of this dividend was Friday, May 17th. AmerisourceBergen’s dividend payout ratio is 24.65%.

In other AmerisourceBergen news, insider Dale Danilewitz sold 5,703 shares of the business’s stock in a transaction on Monday, April 8th. The shares were sold at an average price of $77.22, for a total transaction of $440,385.66. Following the completion of the transaction, the insider now owns 7,874 shares of the company’s stock, valued at approximately $608,030.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard W. Gochnauer sold 8,256 shares of the business’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $84.95, for a total transaction of $701,347.20. Following the transaction, the director now directly owns 20,620 shares of the company’s stock, valued at approximately $1,751,669. The disclosure for this sale can be found here. In the last three months, insiders have sold 51,563 shares of company stock valued at $4,164,135. Company insiders own 27.80% of the company’s stock.

WARNING: This news story was originally published by Riverton Roll and is owned by of Riverton Roll. If you are accessing this news story on another site, it was illegally copied and reposted in violation of US & international copyright and trademark law. The correct version of this news story can be accessed at https://rivertonroll.com/news/2019/06/14/intrepid-capital-management-inc-increases-holdings-in-amerisourcebergen-corp-nyseabc.html.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Featured Article: What is a stock buyback?

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.